Setting up a PDXO platform of pancreatic cancer with spatial-omics characterization

Research output: Unpublished contribution to conferencePoster

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is known for its aggressive biology and lethality. Superior to conventional biomedical research models, the focus of this study is on the development and use of well-established patient-derived organoids (PDO)- and xenografts (PDX), mimicking the tumor as it is present in a human body. The models are extensively analysed using advanced spatial-omics analysis to investigate the ability to recapitulate two main molecular subtypes of PDAC.
Original languageEnglish
Publication statusUnpublished - 2021
EventEuropean Pancreatic Club - Verona - online event
Duration: 9 Jun 202111 Jun 2021

Conference

ConferenceEuropean Pancreatic Club
Period9/06/2111/06/21

Fingerprint

Dive into the research topics of 'Setting up a PDXO platform of pancreatic cancer with spatial-omics characterization'. Together they form a unique fingerprint.

Cite this